InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,111.82
(
0.35%
)
Post# of 1954
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

roadkilll

Send PM Follow Ignore
Followers 7
Posts 578
Boards Moderated 0
Alias Born 08/25/2012

roadkilll

Re: None

Friday, 11/05/2021 12:40:36 PM

Friday, November 05, 2021 12:40:36 PM

Post# of 1954
Viking and Madrigal are in competition with their beta thyroid agonist. Viking eventually will be the DOC.
Madrigal just released an update on their open label phase III trial showing strong evidence for approval for their drug will now just be waiting on the double blinded biopsy confirmed arm in 2022. Basically de-risked the drug for approval.

Gilead has paid over a billion for early stage NASH drugs that never showed efficacy comparable to Vikings 2809. Gilead has had multiple buys and co-devlopment deals with lesser drugs. Better, Vikings CEO has made it very clear in the last CC that the company knows 2809 will be a drug for big pharma to market.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent VKTX News
More VKTX News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!